PCR63 Using Patient Preference to Inform Ritlecitinib Dose Selection for Alopecia Areata Treatment
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.1998
https://www.valueinhealthjournal.com/article/S1098-3015(22)04203-6/fulltext
Section Title :
Section Order :
11554
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)04203-6&doi=10.1016/j.jval.2022.09.1998